Congenital heart defects (CHDs) are structural abnormalities of the heart present from birth, affecting its function and blood flow. These defects can range from simple issues, like small holes in the heart's walls, to complex malformations involving multiple heart structures, requiring specialized medical interventions to ensure proper heart function and improve the patient's quality of life.
Congenital heart defect (CHD) repair is a specialized field within pediatric cardiology and cardiac surgery that focuses on correcting structural abnormalities of the heart present from birth. These defects can vary widely in type and severity, ranging from simple issues like small holes between heart chambers to complex malformations involving multiple parts of the heart and major blood vessels.
Congenital heart defects (CHDs) are structural abnormalities in the heart that are present at birth. These defects occur when the heart or its major blood vessels do not develop properly during fetal development. CHDs can vary widely in type and severity, ranging from simple conditions that may not require treatment to complex malformations that necessitate immediate surgical intervention. The exact cause of most congenital heart defects is not well understood, but they are thought to result from a combination of genetic and environmental factors.
The diagnosis of congenital heart defects often occurs prenatally through ultrasound or shortly after birth through physical examination and echocardiography. Early detection is crucial for planning appropriate interventions and improving outcomes. Treatment for CHDs can range from watchful waiting for minor defects to medications, catheter-based procedures, and open-heart surgery for more severe cases.
Congenital heart defects (CHDs) encompass a diverse array of structural abnormalities in the heart present at birth. These defects can significantly impact heart function and blood flow, necessitating various medical interventions. Understanding the types of CHDs is crucial for diagnosis and treatment.
One common type is septal defects, which include atrial septal defects (ASDs) and ventricular septal defects (VSDs). ASDs are holes in the septum that separates the heart's upper chambers (atria), while VSDs are holes in the septum dividing the lower chambers (ventricles). These defects allow oxygen-rich and oxygen-poor blood to mix, leading to inefficient circulation and increased heart workload.
Valve defects are another category, involving abnormalities in the heart's valves. Examples include pulmonary valve stenosis, where the valve controlling blood flow from the heart to the lungs is narrowed, and aortic valve stenosis, where the valve regulating blood flow from the heart to the body is narrowed. These defects can obstruct blood flow, forcing the heart to work harder and potentially leading to heart failure if untreated.
Tetralogy of Fallot is a complex CHD consisting of four defects: a ventricular septal defect, pulmonary stenosis, right ventricular hypertrophy (thickening of the right ventricular muscle), and an overriding aorta (where the aorta is positioned above the VSD instead of the left ventricle). This combination reduces the amount of oxygen reaching the body, often causing cyanosis (a bluish tint to the skin).
Transposition of the great arteries (TGA) is a severe CHD where the two main arteries leaving the heart—the pulmonary artery and the aorta—are switched. This defect prevents proper oxygenation of blood, necessitating immediate surgical correction after birth.
Another serious CHD is coarctation of the aorta, a narrowing of the aorta that obstructs blood flow from the heart to the body. This condition can lead to high blood pressure and heart damage if not addressed promptly.
Hypoplastic left heart syndrome (HLHS) is a critical CHD where the left side of the heart is underdeveloped, affecting the heart's ability to pump blood effectively. HLHS requires a series of complex surgeries soon after birth to ensure adequate blood flow to the body.
Patent ductus arteriosus (PDA) is a condition where the ductus arteriosus, a blood vessel that allows blood to bypass the lungs in utero, fails to close after birth. This can lead to increased blood flow to the lungs and heart, potentially causing heart failure.
Repairing congenital heart defects (CHDs) involves a range of surgical and minimally invasive procedures aimed at correcting structural abnormalities in the heart present from birth. The specific approach to repair depends on the type and severity of the defect, the patient’s age, and overall health.
Septal defects, such as atrial septal defects (ASDs) and ventricular septal defects (VSDs), involve holes in the walls separating the heart's chambers. These are typically repaired through surgical or catheter-based techniques. Surgical repair involves making an incision in the chest and using a patch or stitches to close the hole. Catheter-based procedures use a thin tube inserted through a blood vessel to deliver a closure device to the defect, which is then deployed to seal the hole.
Valve defects like pulmonary valve stenosis or aortic valve stenosis are addressed through procedures that either repair or replace the affected valve. In some cases, balloon valvuloplasty is performed, where a balloon-tipped catheter is threaded through a blood vessel to the narrowed valve. The balloon is inflated to widen the valve opening, improving blood flow. For more severe cases, valve replacement surgery may be necessary, involving the implantation of a mechanical or biological valve.
Tetralogy of Fallot, a complex CHD consisting of four defects, requires a combination of surgical procedures. The ventricular septal defect is closed with a patch, and the pulmonary stenosis is relieved by removing the obstructing muscle tissue or using a patch to widen the pulmonary artery. This restores normal blood flow and improves oxygenation.
In cases of transposition of the great arteries (TGA), a surgical procedure called an arterial switch operation is performed. This involves repositioning the major arteries—the aorta and the pulmonary artery—to their correct locations, ensuring that oxygen-rich blood is properly circulated throughout the body. This surgery is typically done in the first few weeks of life to prevent severe complications.
Coarctation of the aorta, a narrowing of the aorta, is repaired by surgically removing the narrowed section and reconnecting the healthy ends. In some cases, a patch or a stent may be used to widen the narrowed area. This procedure restores normal blood flow from the heart to the body and reduces the risk of high blood pressure and heart damage.
Hypoplastic left heart syndrome (HLHS) is addressed through a series of staged surgeries. The initial procedure, usually performed in the first few days of life, is called the Norwood operation, which redirects blood flow to ensure sufficient oxygenation. This is followed by the Glenn procedure at 4 to 6 months of age and the Fontan procedure at 2 to 3 years of age, which further improve blood flow and heart function.
Patent ductus arteriosus (PDA) is repaired through minimally invasive catheter-based techniques or surgical ligation. In catheter-based closure, a device is threaded through a blood vessel to the PDA and deployed to seal the duct. Surgical ligation involves making a small incision to tie off or clip the PDA, stopping abnormal blood flow.
Congenital heart defect (CHD) repair is necessary for individuals born with structural abnormalities of the heart that can affect its function and overall health. The need for CHD repair varies depending on the type and severity of the defect, the presence of symptoms, and the potential for complications if left untreated.
Infants and young children are the primary candidates for CHD repair, as many congenital heart defects are diagnosed either prenatally through fetal ultrasounds or shortly after birth. Early intervention is often crucial for severe defects to ensure proper heart function and prevent life-threatening complications. For example, critical conditions such as hypoplastic left heart syndrome (HLHS), transposition of the great arteries (TGA), and Tetralogy of Fallot typically require immediate surgical intervention within the first few days or weeks of life. These procedures are essential to ensure adequate oxygenation and blood flow, supporting the child's growth and development.
Children and adolescents with less severe defects or those that are initially asymptomatic may also require surgical repair as they grow. Conditions such as atrial septal defects (ASDs) and ventricular septal defects (VSDs) might be monitored initially, but if they lead to symptoms such as fatigue, growth retardation, or recurrent respiratory infections, surgical repair becomes necessary. Additionally, valve defects like pulmonary valve stenosis or aortic valve stenosis that cause obstruction and increased workload on the heart often necessitate repair to prevent heart failure and other complications.
Adults with congenital heart defects may also require repair, especially if the defect was not diagnosed or treated during childhood. Some defects, such as small septal defects, may go unnoticed until later in life when they start causing symptoms or complications. Adults who underwent CHD repair as children might need additional surgeries or interventions if the initial repair deteriorates or if new complications arise. Furthermore, women with CHDs who are planning pregnancy may need assessment and potential repair to ensure their heart can handle the increased demands of pregnancy and childbirth.
Treatment options for congenital heart defects (CHDs) are diverse and tailored to the specific type and severity of the defect, as well as the patient's age, overall health, and symptoms. The primary goal of treatment is to correct the structural abnormalities in the heart, improve blood flow, and enhance the patient's quality of life.
Watchful Waiting and Medications: For mild CHDs that do not cause significant symptoms, a watchful waiting approach may be adopted. This involves regular monitoring by a cardiologist to track the progression of the defect and any potential complications. In some cases, medications may be prescribed to manage symptoms and prevent complications. For example, diuretics can help reduce fluid buildup in the lungs, while beta-blockers and ACE inhibitors can improve heart function and lower blood pressure.
Catheter-Based Interventions: Many CHDs can be treated using minimally invasive catheter-based techniques. These procedures involve threading a thin, flexible tube (catheter) through a blood vessel to the heart, guided by imaging technology. Common catheter-based interventions include: Balloon Valvuloplasty, Device Closure, & Stent Placement.
Surgical Interventions: For more complex or severe CHDs, surgical intervention may be necessary. Types of surgeries include: Open-Heart Surgery, Norwood Procedure, Glenn Procedure, and Fontan Procedure.
Implantable Devices: In some cases, implantable devices such as pacemakers or implantable cardioverter-defibrillators (ICDs) may be used to manage arrhythmias (irregular heartbeats) associated with CHDs. These devices help regulate the heart's electrical activity and prevent life-threatening arrhythmias.
Hybrid Procedures: Hybrid procedures combine surgical and catheter-based techniques to treat complex CHDs. These procedures are performed in specialized hybrid operating rooms that allow for seamless integration of surgical and interventional cardiology approaches.
Heart Transplantation: In rare and severe cases where other treatment options are not viable, heart transplantation may be considered. This involves replacing the patient's heart with a donor heart and is typically reserved for patients with severe heart failure or complex CHDs that cannot be corrected through other means.
Repairing congenital heart defects (CHDs) is often essential for improving a patient's quality of life and ensuring proper heart function. However, like any medical intervention, CHD repair comes with its share of risks that must be carefully considered and managed. Understanding these risks is crucial for informed decision-making and effective postoperative care.
One of the primary risks associated with CHD repair is bleeding. Since these surgeries often involve intricate work on the heart and major blood vessels, there is a significant risk of bleeding during and after the procedure. Surgeons use meticulous techniques to control bleeding, but in some cases, patients may require blood transfusions or additional interventions to manage blood loss.
Infection is another critical risk. The introduction of surgical instruments and implants into the body creates opportunities for bacteria to enter and cause infections. Despite strict aseptic techniques and the use of prophylactic antibiotics, infections can still occur. Infections at the surgical site or within the heart can lead to complications requiring further treatment, prolonged hospital stays, or additional surgeries.
Cardiac complications are a major concern during and after CHD repair. The heart may respond unpredictably to the stress of surgery, leading to arrhythmias (irregular heartbeats), heart attack, or heart failure. Patients with pre-existing heart conditions or those undergoing complex surgeries are at higher risk for these complications. Close monitoring of the patient's heart function during and after the procedure is essential to promptly address any issues that arise.
Blood clot formation is another significant risk associated with CHD repair. Surgical manipulation of blood vessels and heart tissue can lead to the formation of blood clots, which can travel to other parts of the body and cause serious complications such as stroke, pulmonary embolism, or deep vein thrombosis (DVT). Patients are often given anticoagulant medications to prevent clot formation, but careful monitoring is necessary to balance the risk of bleeding.
Damage to the heart or surrounding structures is a potential risk, particularly in complex or minimally invasive procedures. The use of catheters, surgical instruments, and energy sources to repair defects can inadvertently damage healthy heart tissue or nearby structures such as the lungs, esophagus, or nerves. This damage can result in complications that may require additional interventions.
For patients undergoing the implantation of devices like pacemakers or implantable cardioverter-defibrillators (ICDs), there is a risk of device-related complications. These can include lead dislodgement, device malfunction, or infection at the implantation site. Regular follow-up appointments and monitoring are essential to ensure the proper functioning of these devices and to address any issues that may arise.
Additionally, there are general anesthesia-related risks associated with CHD repair. These can include allergic reactions, respiratory complications, or adverse effects on the cardiovascular system. Thorough preoperative evaluation and careful anesthetic management are crucial to minimizing these risks.
Recovery from congenital heart defect (CHD) repair is a critical phase that requires careful monitoring, follow-up care, and lifestyle adjustments to ensure optimal outcomes and minimize potential complications. The recovery process can vary widely depending on the type and severity of the defect, the specific surgical procedure performed, and the patient's overall health.
Immediately after the surgery, patients are typically moved to a recovery area or an intensive care unit (ICU) for close observation. During this time, the medical team monitors vital signs, heart function, and the surgical site to detect any early signs of complications. Pain management is a key component of postoperative care, with medications provided to alleviate discomfort.
For minimally invasive procedures, such as catheter-based interventions, patients may only require a short hospital stay, often just one or two days. However, for more complex surgeries, such as open-heart procedures or staged repairs for conditions like hypoplastic left heart syndrome (HLHS), the hospital stay may be longer to ensure thorough monitoring and support during the initial recovery phase.
Once discharged from the hospital, patients receive detailed instructions on how to care for themselves at home. Wound care is essential to prevent infection, and patients are advised to keep the surgical site clean and dry. Activity restrictions are typically recommended, with guidelines to avoid strenuous activities and heavy lifting for several weeks. Light activities, such as walking, are encouraged to promote circulation and prevent blood clots.
Follow-up appointments are a crucial aspect of CHD repair recovery. During these visits, healthcare providers assess the patient's progress, monitor heart function, and make any necessary adjustments to the treatment plan. For patients with implanted devices, such as pacemakers or implantable cardioverter-defibrillators (ICDs), regular checks ensure proper device functioning and timely interventions if issues arise.
Cardiac rehabilitation programs may also be recommended to help patients regain strength and improve cardiovascular health. These programs typically include structured exercise sessions, educational components, and psychological support to address the emotional aspects of recovery. Lifestyle modifications, such as adopting a heart-healthy diet, quitting smoking, and managing stress, are important for long-term heart health and preventing future complications.
Emotional and psychological support is also vital during the recovery process. Patients and their families may experience anxiety, depression, or stress related to the surgery and its aftermath. Support groups, counseling, and mental health services can provide valuable resources to help patients cope with these challenges.
Equipped hospitals, and advanced specialized centers with experienced doctors and specialists are available in all medical treatment areas in Iran. Also, good hotels and entertainment centers have made Iran an appropriate choice for patients who need Congenital heart defect repair.
The cost of congenital heart defect (CHD) repair in Iran can vary significantly based on the type of defect, the complexity of the procedure, and the healthcare facility chosen. Generally, Iran offers high-quality medical services at more affordable prices compared to many other countries, making it an attractive destination for medical tourism. The cost of congenital heart defect repair in Iran ranges around 7,000-10,000 USD. The cost of congenital heart defect repair in Iran is generally more affordable compared to many other countries, making it an appealing option for patients seeking high-quality medical care at a lower cost. The affordability, combined with the expertise of Iranian cardiac surgeons and the availability of advanced medical technology, ensures that patients receive effective and efficient treatment for congenital heart defects.
Congenital heart defects (CHDs) that often require surgical repair include atrial septal defects (ASDs), ventricular septal defects (VSDs), Tetralogy of Fallot, transposition of the great arteries (TGA), coarctation of the aorta, and hypoplastic left heart syndrome (HLHS).
Immediately after surgery, patients are typically monitored in an intensive care unit (ICU) for close observation. Pain management, wound care, and activity restrictions are important aspects of the recovery process. Patients may gradually resume light activities as healing progresses, and regular follow-up appointments are essential to monitor the heart's function and ensure proper recovery.
While congenital heart defect repair is often necessary to improve heart function and overall health, it carries certain risks. These include bleeding, infection, cardiac complications (such as arrhythmias or heart failure), blood clot formation, and damage to the heart or surrounding structures.
Consistently ranked as one of the Top Hospitals in Iran
Bahman Super Speciality Hospital has 200 official beds
Ranked the biggest and most equipped private treatment center in Iran
The first private hospital in Iran to get the Green Award International Certification
The first private PET scan center equipped with PET-CT, PET-MAMMO, Cyclotron, and Conventional Nuclear Medicine
The first private super specialty ophthalmology hospital in Iran.
Considering the increasing expansion of Mashhad city and medical needs in 1973.
One of the best-equipped diagnostic and therapeutic cardiology centers in the region.